Trajectories of symptom severity predicts quality of life change in newly diagnosis lymphoma survivors: An initial study

Chih Jung Wu, Yu Chi Chen, Li Yuan Bai, Tzeon Jye Chiou, Kuan Chia Lin, Ya Jung Wang

Research output: Contribution to journalArticlepeer-review


Objective: This study aimed to explore the subgroups of symptom severity and impact of their trajectories on quality of life in lymphoma survivors. Methods: Secondary data were analysed from a prospective study with four-time measures: before treatment (T1), during treatment (T2), treatment completion (T3) and 10 weeks after treatment (T4). Data were analysed using descriptive statistics, group-based trajectory model and generalised estimation equation. Results: Fifty nine of 61 participants completed three-time measure (mean age = 60.43 years, male-predominant). The changes in symptom severity over time were divided into two subgroups: slight-stable group (n = 54, 89%) and mild-fickle group (n = 7, 11%). Pain, tiredness and sleeping trouble were the predominant symptoms. The quality of life change in the slight-stable group was significantly better than that of the mild-fickle group (B = 13.35, SE = 3.53, p < 0.001). The overall quality of life at T2, T3 and T4 was better than it was at T1. Conclusion: The different trajectories of symptom severity significantly influenced quality of life changes in lymphoma survivors. Healthcare providers must be aware that there is a group of lymphoma survivors with relatively severe symptoms when newly diagnosed, compared to the opposite. More attention must be paid to this group, in addition to providing in-time symptom management.

Original languageEnglish
Article numbere13741
JournalEuropean Journal of Cancer Care
Issue number6
Publication statusPublished - Nov 2022


  • lymphoma survivors
  • predominant symptoms
  • quality of life
  • trajectories of symptom severity

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Trajectories of symptom severity predicts quality of life change in newly diagnosis lymphoma survivors: An initial study'. Together they form a unique fingerprint.

Cite this